Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Olmutinib |
Trade Name | |
Synonyms | HM61713|BI 1482694|BI1482694|BI-1482694 |
Drug Descriptions |
Olmutinib (BI1482694, HM61713) is a third-generation EGFR inhibitor that inhibits activating mutations in EGFR, including those occurring with T790M, and spares wild-type EGFR, potentially resulting in decreased tumor growth (PMID: 25027951, PMID: 25521095, PMID: 30356705, PMID: 32830792, PMID: 32679450). |
DrugClasses | EGFR Inhibitor 3rd gen 26 |
CAS Registry Number | 1353550-13-6 |
NCIT ID | C101791 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Olmutinib | Olmutinib | 0 | 1 |